12
Limits and Realities of ART Scale-up
Alex Coutinho
Infectious Diseases Inst, Makerere Univ, Kampala, Uganda
Since 2002, when WHO announced the 3X5 target, there has
been a remarkable scale-up of ART driven by resources from the Global Fund and
PEPFAR in particular and supported by an unprecedented partnership of HIV+
people and numerous government and non-government actors. As of the end of
2007, there were an estimated 3,000,000 on ART of whom 2,000,000 were in
Sub-Saharan Africa. However these figures still represent only 30% of those in
need of ART, and the estimated 200,000 children on ART are only 10% of those
who should be on treatment. Current constraints to further rapid scale-up of
ART include lack of knowledge of one’s HIV status or lack of awareness of when
to start ART. Additional limits to further scale-up of ART could include a
limitation in the global funding levels needed to maintain current
beneficiaries and support additional millions to start treatment. Other real
barriers are the exhaustion of the health system in developing countries, as
well as the challenge of how to take treatment to hard to reach population
groups. Among those who do manage to start treatment, several studies indicate
a high level of early deaths and loss to follow-up, particularly in the first
12 months of initiation of treatment. In addition, longer term drug adherence continues
to be a challenge with the reported emergence of drug resistance, drug
toxicities, and other disabling chronic disorders. Several countries continue
to be challenged with logistics and infrastructure, particularly the laboratory
services necessary to diagnose and monitor complicated cases. Other emerging
social challenges to the scale-up of ART include the challenge of providing
sexual and reproductive health services for HIV+ persons who wish to
resume or continue safe sexual activity, the economic challenges of being
alive, feeling well but having to find a job; or how to juggle a job while
receiving chronic care. In addition, there is also the re-emergence of stigma
issues—particularly when denial of one’s HIV status is needed to fully
reintegrate into society.
|